Publications by authors named "Nader Youssef"

Claim this Profile
E
Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon-in-continuity: A multicenter, open-label, metabolic balance study.
Astrid Verbiest, Mark Krogh Hvistendahl, Federico Bolognani, Carrie Li, Nader N Youssef

Clin Nutr· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Tolerability of a Single Dose of Apraglutide, a Novel, Long-Acting, Synthetic glucagon-like peptide-2 Analog With a Unique Pharmacologic Profile, in Individuals With Impaired Renal Function.
Gérard Greig, Nader N Youssef, Federico Bolognani

J Clin Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2.
Robert Zeiser, Yi-Bin Chen, Nader N Youssef, Francis Ayuk

Br J Haematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey.
Loris Pironi, Ezra Steiger, Francisca Joly, Palle B Jeppesen, Geert Wanten, Nader N Youssef

Clin Nutr ESPEN· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.
Ken Fujioka, Khursheed Jeejeebhoy, Ulrich-Frank Pape, Benjamin Li, Nader N Youssef

JPEN J Parenter Enteral Nutr· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Kishore R Iyer, Marek Kunecki, Joseph I Boullata, Ken Fujioka, Francisca Joly, Nader N Youssef

JPEN J Parenter Enteral Nutr· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
Beth A Carter, Valeria C Cohran, Conrad R Cole, Mark R Corkins, Reed A Dimmitt, Nader N Youssef

J Pediatr· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Trali or acute post-transfusion pulmonary edema: report of a case with review of the literature].
Issam Serghini, Youssef Nader, Youssef Qamouss, Mohamed Zoubir, Jaafar Salim Lalaoui

Pan Afr Med J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Secondary pathological fractures of benign tumors in children: about 20 cases].
Youssef Nader, Idrissi Khalid Koulali, Salahi Hicham

Pan Afr Med J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Humeral localization of a recurrent giant cell tumor (about one case)].
Youssef Nader, Issam Serghini, Idrissi Khalid Koulali, Hicham Salahi, Farid Galwia

Pan Afr Med J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Isolated latent scaphoid dislocation in children: report of a case].
Youssef Nader, Khalid Idrissi Koulali

Pan Afr Med J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Lauren K Schwartz, Stephen J D O'Keefe, Ken Fujioka, Simon M Gabe, Georg Lamprecht, Nader N Youssef

Clin Transl Gastroenterol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
Mark A Gilger, Vasundhara Tolia, Yvan Vandenplas, Nader N Youssef, Barry Traxler

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
Vasundhara Tolia, Nader N Youssef, Mark A Gilger, Barry Traxler, Marta Illueca

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
Mark A Gilger, Vasundhara Tolia, Yvan Vandenplas, Nader N Youssef, Barry Traxler

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
Vasundhara Tolia, Nader N Youssef, Mark A Gilger, Barry Traxler, Marta Illueca

J Pediatr Gastroenterol Nutr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials.
Douglas L Seidner, Francisca Joly, Nader N Youssef

Clin Transl Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetic properties of esomeprazole in children aged 1 - 11 years with endoscopically proven GERD: a randomized, open-label study.
Nader N Youssef, Eduardo Tron, Vasundhara Tolia, Jennifer E Hamer-Maansson, Per Lundborg

Int J Clin Pharmacol Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lubiprostone for the treatment of functional constipation in children.
Paul E Hyman, Carlo Di Lorenzo, Laurel L Prestridge, Nader N Youssef, Ryuji Ueno

J Pediatr Gastroenterol Nutr· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects.
Jolene Kay Berg, Eric H Kim, Benjamin Li, Bo Joelsson, Nader N Youssef

BMC Gastroenterol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of abdominal pain through global outcomes and recent FDA recommendations in children: are we ready for change?
Saeed Mohammad, Carlo Di Lorenzo, Nader N Youssef, Adrian Miranda, Samuel Nurko

J Pediatr Gastroenterol Nutr· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month follow-up of cognitive behavioral therapy for children with functional abdominal pain.
Rona L Levy, Shelby L Langer, Lynn S Walker, Joan M Romano, Dennis L Christie, Nader Youssef

JAMA Pediatr· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inverse relationship of interleukin-6 and mast cells in children with inflammatory and non-inflammatory abdominal pain phenotypes.
Wendy A Henderson, Ravi Shankar, Tara J Taylor, Arseima Y Del Valle-Pinero, David E Kleiner, Nader N Youssef

World J Gastrointest Pathophysiol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical update and potential advances in the treatment of pediatric intestinal failure.
Nader N Youssef, Adam G Mezoff, Beth A Carter, Conrad R Cole

Curr Gastroenterol Rep· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole formulary exclusion: impact on total health care services use and costs.
Berhanu Alemayehu, Xiongkan Ke, Nader N Youssef, Joseph A Crawley, Douglas S Levine

Postgrad Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis